2019 Modern Radiotherapy for Hematologic Malignancies

Attendee Policies

Cancellation Statement

ASTRO reserves the right to cancel the 2019 Modern Radiotherapy for Hematologic Malignancies meeting because of unforeseen circumstances.

View information on the Registration Cancellation Policy.

Equal Opportunity Statement

ASTRO events and activities are available without regard to race, color, sex, national origin, disability, age or veteran status as provided by law and in accordance with the Society’s respect for personal dignity.

Age Requirement for Attendees

Because of the detailed nature of the programs and forums, no one under the age of 18 will be admitted to any official ASTRO function. This includes, but is not limited to, all sessions.

Access to Your Contact Information

Your registration information is being used by ASTRO in various ways to facilitate meeting operations.  The 2019 Modern Radiotherapy for Hematologic Malignancies Meeting, including registration and housing and use of any personal information obtained, is governed by ASTRO's Terms of Use and Privacy Policy.

Physician Payments Sunshine Act (Sunshine Act)

Signed into law in 2010 as part of the Affordable Care Act, the Physician Payments Sunshine Act (Sunshine Act) requires manufacturers, including certain distributors, of medical devices, drugs, biologicals and medical supplies to track and report ownership interests as well as certain payments made to and transfers of value provided to physicians and teaching hospitals. Effective August 1, 2013, manufacturers were required to begin collecting information about payments, transfers of value and ownership interests and to submit these reports to the Centers for Medicare and Medicaid Services (CMS) on an annual basis. A payment or, transfer of value must be reported when it is valued at $10 or more, or if valued at less than $10, when the sum of all items/payments/transfers of value given to a particular recipient over a year exceeds $100. The majority of the information contained in these reports will be available on a public, searchable website. Physicians will have the right to review their reports and challenge reports that are false, inaccurate or misleading.

Please note that exhibitors or other parties covered by the Sunshine Act may track and report items, meals or other transfers of value that they provide to you during the 2019 Modern Radiotherapy for Hematologic Malignancies meeting in accordance with their interpretation of the requirements set forth in the Sunshine Act and regulations.

View more information on the Sunshine Act and access the CMS website.

Recording (Audio, Video and Still Photography)

Any photography, filming, taping, recording or reproduction in any medium, including via the use of tripod-based equipment and mobile devices of any of the programs and/or posters presented at the 2019 Modern Radiotherapy for Hematologic Malignancies, without the express written consent of the American Society for Radiation Oncology is strictly forbidden.


The University of California, San Diego - ACTRI and the Sheraton La Jolla are non-smoking facilities.

Special Assistance

ASTRO is committed to making the 2019 Modern Radiotherapy for Hematologic Malignancies meeting accessible to all individuals. If you have a disability as identified in the Americans with Disabilities Act, please contact the Meetings Department at 703-839-7390.

Security and Attendee Conduct Information

For security reasons, the 2019 Modern Radiotherapy for Hematologic Malignancies badge will be required for admittance to all events. Badges should be worn and visible at all times. Lost badges should be reported to the Registration staff immediately. The following badge policies will be in effect throughout the conference:

  1. 2019 Modern Radiotherapy for Hematologic Malignancies badges are the sole property of ASTRO.
  2. Badges are not transferable.
  3. False certification of individuals as paid 2019 Modern Radiotherapy for Hematologic Malignancies attendees, misuse of badges, any method of assisting unauthorized persons to gain access to any 2019 Modern Radiotherapy for Hematologic Malignancies event, or any inappropriate or unauthorized conduct will be just cause for repossessing badge of any individuals involved and expelling all parties involved from the Meeting without obligation on the part of ASTRO for refund of any fees.

In addition, individuals who are part of 2019 Modern Radiotherapy for Hematologic Malignancies may not engage in any demonstrations or other behavior that ASTRO deems potentially disruptive to the conduct of the Meeting. Violation of this rule is grounds for immediate dismissal from the meeting and/or ineligibility for attendance at future ASTRO events. Any person who is dismissed from the meeting may request that ASTRO review the matter, provided, however, that the individual understands that such dismissal will be effective immediately and will continue until and unless ASTRO issues a contrary decision.

ASTRO Photography

ASTRO has reserved the right to document and capture events at 2019 Modern Radiotherapy for Hematologic Malignancies. An individual attending 2019 Modern Radiotherapy for Hematologic Malignancies understands that their image or likeness may be captured in the photographs taken during the meeting and grants ASTRO unrestricted permission to use and publish photographs or video images of themself for any purpose authorized by ASTRO, including but not limited to website use, publications, promotional marketing and advertising use, etc.

Amendment to Attendee Policies

Any matters not specifically covered by these Attendee Policies shall be subject solely to the decision of ASTRO. ASTRO may, at any time, amend or add further policies, and all amendments and/or additions made shall be binding on all attendees equally along with the foregoing Attendee Policies.